Differences and variability in plasma noradrenaline between depressive and anxiety disorders

Journal of Psychopharmacology

Volumn 12, Issue 2, 1998, Pages 161-167

  Kelly, C B ^a,b   Cooper, S J ^a  

^a QUEEN'S UNIVERSITY BELFAST   (United Kingdom)

^b BELFAST CITY HOSPITAL   (United Kingdom)

Author keywords

Cortisol; Depressive illness; Dysregulation; Melancholic; Noradrenaline; Variance

Indexed keywords

HYDROCORTISONE; NORADRENALIN;

ADULT; AGED; ANXIETY NEUROSIS; ARTICLE; CONTROLLED STUDY; DEPRESSION; FEMALE; HUMAN; HYDROCORTISONE BLOOD LEVEL; MAJOR CLINICAL STUDY; MALE; NORADRENALIN BLOOD LEVEL; NORADRENERGIC SYSTEM; PRIORITY JOURNAL; PSYCHOSIS; WEIGHT REDUCTION;

EID: 0031863936     PISSN: 02698811     EISSN: None     Source Type: Journal    
DOI: 10.1177/026988119801200208     Document Type: Article

References (66)

1. Ableson J L, Glitz D, Cameron O G, Lee M A, Branzo M, Curtis G C (1991) Blunted growth hormone response to clonidine in patients with generalised anxiety disorder. Archs Gen Psychiat 48: 157-162
2. American Psychiatric Association (1987) Diagnostic and statistical manual of mental disorders, 3rd edn (revised). American Psychiatric Association, Washington, DC
3. Anderson I M, Parry-Billings M, Newsholme E A, Poartmans J R, Cowen PJ (1990) Decreased plasma tryptophan concentrations in major depression: relationship to melancholia and weight loss. J Affect Disord 20: 185-191
4. Armitage P, Berry G (1987) Statistical methods in medical research. Blackwell Scientific Publications, Oxford, pp. 112-115
5. Barnes R F, Veith R C, Barson S, Verhey J, Raskind M A, Halter J B (1983) High levels of plasma catecholamines in dexamethasone resistant depressed patients. Am J Psychiat 140: 1623-1625
6. Blum I, Nissiel L, David A, Graff E, Harsat A, Weissglass L, Gabboy U, Sulkes J, Yerushalmy Y, Vered Y (1992) Plasma neurotransmitter profile during different phases of the ovulatory cycle. J Clin Endocrinol Metab 75: 924-929
7. Brown M J, Jenner D A, Allison D J, Dollery C T (1981) Variations in individual organ release of noradrenaline measured by an improved radioenzymatic technique: limitations of peripheral venous measurements in the assessment of sympathetic nervous activity. Clin Sci 61: 585-590
8. Cameron O G, Smith C B, Lee M A, Hollingsworth P G, Hill E M, Curtis G C (1990) Adrenergic status in anxiety disorders: platelet alpha-2-adrenergic receptor binding, blood pressure, pulse and plasma catecholamines in panic and generalised anxiety disorder patients and normal subjects. Biol Psychiat 28: 3-20.
9. Checkley S A, Glass I B, Thompson L, Corn T, Robinson P (1981) The G H response to clonidine in endogenous as compared with reactive depression. Psychol Med 14: 773-777
10. Christensen N J (1974) Plasma norepinephrine and epinephrine in untreated diabetes, during fasting and after insulin administration. Diabetes 23: 1-8
11. Danish University Antidepressant Group (1990) Paroxetine: a selective serotonin uptake inhibitor showing better tolerance but weaker antidepressant effect than clomipramine in a controlled multicentre study. J Affect Disord 18: 289-299
12. DeVilliers A S, Russell V A, Carsters M E, Aalbers C, Gagiano C A, Charlton D O, Taljaard J F (1987) Noradrenergic function and hypothalamic-pituitary-adrenal axis activity in primary major depressive disorder. Psychiat Res 21: 127-139
13. Dinan T G, Yatham L N, O'Keane V, Barry S (1991) Blunting of noradrenergic stimulated growth hormone release in mania. Am J Psychiat 148: 936-938
14. Duggan C F, Lee A S, Murray R M (1991) Do different subtypes of hospitalised depressives have different outcomes? Archs Gen Psychiat 48: 308-312
15. Dutka D P, Olvatto I, Ward S, Nihoyannopoulos P, Al-Subaibi M, Oakley C M, Impallomeni M, Cleland J G (1995) Plasma neuroendocrine activity in very elderly subjects and patients with and without heart failure. Europ Heart J 16: 1223-1230
16. Elsworth J D, Redmond D E, Roth R H (1982) Plasma and cerebrospinal fluid 3-methoxy-4-hydroxyphenylethylene glycol (MHPG) as indices of brain norepinephrine metabolism in primates. Brain Res 235: 115-124
17. Esler M D, Turbott J, Schwarz R, Leonard P, Babik A, Skews H, Jackman G (1982) The peripheral kinetics of norepinephrine in depressive illness. Archs Gen Psychiat 39: 295-300
18. Esler M D, Lambert G W, Ferrier C, Kaye D M, Wallin B G, Kalff V, Kelly M J, Jennings G L (1995a) Central nervous system noradrenergic control of sympathetic outflow in normotensive and hypertensive humans. Clin Exp Hypertension 17: 409-423
19. Esler M D, Turner A G, Kaye D M, Thompson J M, Kingwell B A, Morris M, Lambert G W, Jennings G L, Cox H S, Seals D R (1995b) Aging effects on human sympathetic neuronal function. Am J Physiol 268: R278-R285
20. Extein I, Tallman J, Smith C C, Goodwin F K (1979) Changes in lymphocyte beta-adrenergic receptors in depression and mania. Psychiat Res I: 191-197
21. Frank E, Anderson B, Reynolds III C F, Ritenour A, Kupfer D G J (1994) Life events and the research diagnostic criteria endogenous subtype. Archs Gen Psychiat 51: 519-524
22. Goldstein D S, Levinson P, Keiser H R (1983) Plasma and urinary catecholamines during the human ovulatory cycle. Am J Obstet Gynecol 146: 824-829
23. Gustafson A B, Kalkoff R K (1982) Influence of sex and obesity on plasma catecholamine response to isometric exercise. J Clin Endocrinol Metab 55: 703-707
24. Hamilton M (1959) The assessment of anxiety states by rating. Br J Med Psychol 32: 50-55
25. Hamilton M (1967) Development of a rating scale for primary depressive illness. Br J Soc Clin Psychol 6: 278-296
26. Healy D, Paykel E S, Whitehouse A M, White W, Ashby M, Brown M, Theodarou A E, Lawrence K M, Horton R W (1992) Plasma noradrenaline, adrenaline, and DHPG responses to clonidine in control and depressed subjects. Hum Psychopharmac 7: 167-173
27. Hjemdahl P (1987) Physiological aspects of catecholamine sampling. Life Sci 41: 841-844
28. Kopin I J (1984) Avenues of investigation for the role of catecholamines in anxiety. Psychopathology 17: 3-8
29. Krstulovic A M, Dziedzic S W, Bertoni-Dziedzic L, Dirico D E (1981) Plasma catecholamines in hypertension and phaeochromocytoma determined using ion pair reverse phase chromatography with amperometric detection. Investigation of separation mechanism and clinical methodology. J Chromatogr 217: 523-537
30. Lake C R, Pickar D, Zeigler M G, Lipper S, Slater S, Murphy D L (1982) High plasma norepinephrine levels in patients with major affective disorder. Am J Psychiat 139: 1315-1318
31. Lambert G W, Ferrier C, Kaye D M, Jennings G L, Kalff V, Kelly M J, Cox H S, Turner A G, Esler M D (1995) Central nervous system norepinephrine turnover in essential hypertension. Ann N Y Acad Sci 12: 679-694
32. Landsberg L, Young J B (1978) Fasting, feeding and regulation of the sympathetic nervous system. New Engl J Med 298: 1295-1301
33. Lewis A J (1938) States of depression: their clinical and aetiological differentiation. BMJ ii: 875-878
34. Lista A L (1989) Differential rates of urinary noradrenaline excretion in affective disorders: utility of a short time sampling procedure. Psychiat Res 30: 253-258
35. Louis W J, Doyle A E, Anavekar S N (1975) Plasma noradrenaline concentration and blood pressure in essential hypertension, phaeochromocytoma and depression. Clin Sci Mol Med 48: 239S-242S
36. Magliozzi J R, Gietzen D, Maddock R J, Haack D, Doran A R, Goodman T, Weiler P G (1989) Lymphocyte beta-adrenoceptor density in patients with unipolar depression and normal controls. Biol Psychiat 26: 15-25
37. Mann J J, Mahler J C, Wilner P J, Halper J P, Brown R P, Johnson K S, Kocsis J H, Chen J S (1990) Normalisation of blunted lymphocyte beta-adrenergic responsivity in melancholic inpatients by a course of electroconvulsive therapy. Archs Gen Psychiat 47: 461-464
38. Mann J J, Malone K M, Diehl D J, Perel J, Cooper T B, Mintun M A (1996) Demonstration in vivo of reduced serotonin responsivity in the brain of untreated depressed patients. Am J Psychiat 153: 174-182
39. Martignoni E, Blandini F, Melzi d'Eril G V, D'Andrea G, Sances G, Costa A, Nappi G (1993) The influence of gender in the evaluation of platelet and plasma catecholamines. Life Sci 52: 1995-2004
40. Matthew R J, Ho B T, Francis D J, Taylor D L, Weinman M L (1982) Catecholamines and anxiety. Acta Psychiat Scand 65: 142-147
41. Matussek N, Aikenheil M, Hippius H, Muller F, Schroder HT, Schultes H, Wasilewski B (1980) Affects of clonidine on growth hormone release in psychiatric patients and controls. Psychiat Res 2: 25-26
42. Morrow L A, Linares O A, Hill T J, Sanfield J A, Supiano M A, Rosen S G, Halter J B (1987) Age differences in the plasma clearance mechanisms for epinephrine and norepinephrine in humans. J Clin Endocrinol Metab 65: 508-511
43. Munjack D J, Baltazaar P L, De Quattro V, Sabin P, Palmer R, Zulueta A, Crocker B, Usigli R, Buckwalter G, Leonard M (1990) Generalised anxiety disorder: some biochemical aspects. Psychiat Res 32: 35-43
44. Murburg M M, McFall M E, Lewis N, Veith R C (1995) Plasma norepinephrine kinetics in patients with post-traumatic stress disorder. Biol Psychiat 38: 819-825
45. Nelson J C, Mazure C M, Jatlow P I (1990). Does melancholia predict response in major depression. J Affect Disord 18: 157-165
46. Nicholls D O, O'Connor P C, Harrow D W G, Leahey W J, Shanks R G (1984) Differential blockace of alpha-adrenoceptors by indoramin. Br J Clin Pharmac 17: 719-728
47. Odink J, Van der Ploeg H M, Van den Berg J, Van Kempen G M J, Bruinse H W, Lauworse E S (1990) Circadian and circatrigintan rhythms of biogenic amines in premenstrual syndrome. Psychosom Med 52: 346-356
48. Pandey G N, Janicak P G, Jovaid J I, Davis J M (1989) Increased H3-clonidine binding in the platelets of patients with depressive and schizophrenic disorders. Psychiat Res 28: 73-78
49. Paykel E S, Cooper Z, Ramana R, Hayhurst H (1996) Life events social support and marital relationships in the outcome of severe depressions. Psychol Med 26: 121-133
50. Reiner P B (1986) Correlational analysis of central noradrenergic neuronal activity and sympathetic tone in behaving cats. Brain Res 378: 86-96
51. Roose S P, Glassman A H, Attia E (1994) Comparitive efficacy of selective serotonin reuptake inhibitors and tricyclics in the treatment of melancholia. Am J Psychiat 151: 1735-1739
52. Roy A, Pickar D, Linnoila M, Potter W Z (1985) Plasma norepinephrine levels in affective disorders. Archs Gen Psychiat 42: 1181-1185
53. Roy A, Jimerson D C, Pickar D (1986) Plasma MHPG in depressive disorders and relationship to the dexamethasone suppression test. Am J Psychiat 143: 846-851.
54. Roy A, Guthrie S, Pickar D, Linnoila M (1987) Plasma norepinephrine response to cold challenge in depressed patients and normal controls. Psychiat Res 21: 161-168
55. Roy A, Pickar D, De Jong J, Karoum F, Linnoila M (1988) Norepinephrine and its metabolites in cerebrospinal fluid, plasma and urine. Archs Gen Psychiat 45: 849-857
56. Rudorfer M V, Ross R J, Linnoila M, Sherer M A, Potter W Z (1985) Exaggerated orthostatic responsivity of plasma norepinephrine in depression. Archs Gen Psychiat 42: 1186-1192
57. Schildkraut J J (1965) The catecholamine hypothesis of affective disorders: a review of supporting evidence. Am J Psychiat 122: 509-522
58. Segal D S, Kuczenski R, Mandell A J (1974) Theoretical implications of drug induced adaptive regulation for a biogenic amine hypothesis of affective disorders. Biol Psychiat 9: 147-159
59. Sevy S, Papadimitriou G N, Surmont D W, Goldman S, Mendlewicz J (1989) Noradrenergic function in generalised anxiety disorder, major depressive disorder and healthy subjects. Biol Psychiat 25: 141-152
60. Siever L J, Davis K L (1985) Overview: Toward a dysregulation hypothesis of depression. Am J Psychiat 142: 1017-1029
61. Siever L J, Uhde T W, Jimerson D C, Lake C R, Kopin I J, Murphy D L (1986) Indices of noradrenergic output in depression. Psychiat Res 19: 59-73
62. Starkman M N, Cameron O G, Nesse R M, Zebrik T (1990) Peripheral catecholamine levels and the symptoms of anxiety with and without phaeochromocytoma. Psychosom Med 652: 129-142
63. Veith R C, Lewis N, Linares O A, Barnes R F, Raskind M A, Villacres E C, Murburg M M, Ashleigh A, Costillo S, Peskind E R, Pascualy M, Halter J B (1994) Sympathetic nervous system activity in major depression. Archs Gen Psychiat 51: 411-422
64. Wyatt R J, Portnoy B, Kupfer D J, Synder F, Engelman K (1971) Resting plasma catecholamine concentrations in patients with depression and anxiety. Archs Gen Psychiat 24: 65-70
65. Zacur H A, Tyson J E, Ziegler M G, Lake C R (1978) Plasma dopamine-beta-hydroxylase activity and norepinephrine levels during the human menstrual cycle. Am J Obstet Gynecol 130: 148-151
66. Ziegler M G, Lake L R, Wood J H, Brooks B R, Ebert M H (1977) Relationship between norepinephrine in blood and cerebrospinal fluid in the presence of a blood cerebrospinal fluid barrier for norepinephrine. J Neurochem 28: 677-679